Hansoh Pharmaceutical Group Company Limited Financial Overview
Hansoh Pharmaceutical Group Company Limited's market cap is currently HK$210.60B. The company's EPS TTM is HK$0.5780227064000001; its P/E ratio is 40.06; and it has a dividend yield of 1.07%. Hansoh Pharmaceutical Group Company Limited is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is HK$0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CNY
Hansoh Pharmaceutical Group Company Limited Earnings and Revenue History
